Environmental scans and discussion papers
H3 CONSULTING
Health Research & Strategy
Communicated
H3 Consulting offers its clients insightful, actionable health research and strategic advice, focusing on complex challenges that often benefit from collaborative solutions.
H3 specializes in investigating, positioning and communicating private payer issues crucial to employers, insurers, drug manufacturers, health professions, patient groups, governments, industry associations and others to ensure the quality and sustainability of our health plans.
H3 welcomes collaborative projects with other consultants.
Expertise
H3 Consulting provides a unique combination of deep knowledge of the private payer community, health benefit plans and prescription drug policy with advanced research skills and strong communication abilities in three key areas.
1
Prescription drug policy for private and public payers that guides program decisions, including expertise in financing and comparative drug systems.
2
Workplace health strategy and chronic disease management that integrates comprehensive health promotion, health culture, and health and disability benefits with human resources strategy to achieve business goals.
3
Private health insurance market access that applies four decades of experience to help identify the value from the provider, payer and patient perspectives in new drug products and health services.
Services
H3 Consulting specializes in planning, researching and creating:
Presentations for internal and public audiences
Opinion leader surveys and interviews
Meeting facilitation and advisory boards
Training on private drug plans and national drug policy
Client Philosophy - Open Minds
H3 Consulting intentionally aims to open minds with every project, ensuring that solutions are effective, practical and well-communicated. Better understanding engages the parties, overcomes inertia and encourages action.
H3 has helped a wide variety of corporate, professional, association and government organizations see health issues from all sides. Collaborative engagement is an increasingly useful approach to provide richer insight and achieve more than any one party could on their own.
For more than 20 years, H3 Consulting has created a unique, trusted and respected reputation with clients across Canada.
CHRIS BONNETT, MHSc, PhD
Principal Consultant
Chris Bonnett established H3 Consulting in 1999, after 18 years of progressive experience in underwriting, reinsuring, selling, and marketing employee benefits. Dr. Bonnett provides practical prescription drug policy research for private and public drug plan leaders and advises on strategies to improve health in the workplace.
Dr. Bonnett is an accomplished speaker, moderator and facilitator, appearing at more than 150 in-person and web-based conferences for organizations across Canada and in the US. His communication credits also include dozens of health-focused articles.
Dr. Bonnett has been a volunteer director on the Boards of four health service organizations, including a 2019 provincial appointment to the College of Dental Hygienists of Ontario. He taught the business case for workplace health at Humber College and is on the BHSW Program Advisory Committee. He was the longest serving national Advisory Board member (2003-2021) for the Sanofi Canada Healthcare Survey.
He holds a Master’s degree in Health Science from the University of Toronto, and a PhD in drug policy from the School of Public Health and Health Systems at the University of Waterloo.
Resources
These documents and recordings represent selected projects and reports undertaken by H3 Consulting that are publicly available. This list will be periodically updated. An asterisk (*) means used with the permission of the copyright owner.
Cancer in the Workplace
Workplace Health and Health Benefits
National Pharmacare
Product Listing Agreements
Cancer in the Workplace
- Improving the Management of Cancer in the Workplace, with Allan Smofsky, Smofsky Strategic Planning, available through cancerandwork.ca, May 2018.
- Cancer and the Workplace – What employers need to know, with Allan Smofsky, Smofsky Strategic Planning in HR Professional (HRPA), September 2017.
Workplace Health and Health Benefits
- The Business Case for Better Workplace Vision Care Benefits, sponsored by Alcon Canada and BC Doctors of Optometry, May 2020.*
- Moving on from Mediocre – The new business case for workplace health, in Benefits and Pensions Monitor, p. 23-24, December 2019.
- Change for the Better – Do wellness incentives work? It depends on the design, in Benefits Canada, March 2015.
National Pharmacare
- Pharmacare in 2021 – The Path to Meaningful Reform Podcast, with Helen Stevenson, Reformulary Group and David Willows, Green Shield Canada, April 2021.
- National Pharmacare Podcast, with David Willows, Green Shield Canada, June 2020.
- A private payer perspective on pharmacare and other drug policy problems. Podcast interview by Brittany Humphries, PDCI Market Access. June 2020.
- Q&A with Chris Bonnett, Insights, a Telus Health Analytics Publication, December 2019.*
- Recommendations for the Advisory Council on the Implementation of National Pharmacare, published by Longwoods.com, January 2019.
- National pharmacare – Dead and Alive, in Plans & Trusts, International Federation of Employee Benefit Plans, November-December 2017.*
Product Listing Agreements
- Report on the 2020 Private Payer Product Listing Agreement Study, with PDCI Market Access and Connex Health Consulting, September 2020.
- Private Payer Product Listing Agreement Series: Report 4: PLA Perspectives, Comparison and Contrast, with PDCI Market Access. September 2015.
Contact
For more information, please contact Chris Bonnett:
Mobile: 1-416-458-5468 Email: chris@hthree.ca
The most recent project information is always available on LinkedIn